GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Other Current Assets

Theratechnologies (TSX:TH) Other Current Assets : C$2.3 Mil (As of Aug. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Theratechnologies Other Current Assets?

Theratechnologies's other current assets for the quarter that ended in Aug. 2024 was C$2.3 Mil.

Theratechnologies's quarterly other current assets declined from Feb. 2024 (C$3.6 Mil) to May. 2024 (C$3.0 Mil) and declined from May. 2024 (C$3.0 Mil) to Aug. 2024 (C$2.3Mil).

Theratechnologies's annual other current assets declined from Nov. 2021 (C$14.4 Mil) to Nov. 2022 (C$11.1 Mil) declined from Nov. 2022 (C$11.1 Mil) to Nov. 2023 (C$4.5 Mil).


Theratechnologies Other Current Assets Historical Data

The historical data trend for Theratechnologies's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Other Current Assets Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.97 7.46 14.43 11.13 4.51

Theratechnologies Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.50 4.51 3.63 3.01 2.31

Theratechnologies Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


Theratechnologies Other Current Assets Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Theratechnologies Business Description

Traded in Other Exchanges
Address
2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
Executives
Dale Weil Director
Joseph Arena Director
Philippe Dubuc Senior Officer
Gérald A. Lacoste Director
Paul Lévesque Senior Officer
Andrew Molson Director
Dawn Svoronos Director
John Leasure Senior Officer
Alain Trudeau Director
Sheila Frame Director
Gary Peter Littlejohn Director
Marie-noël Colussi Senior Officer
Jovan Antunovic Senior Officer
Christian Marsolais Senior Officer
Jocelyn Lafond Senior Officer